Evidence map›Paper›PMID 39816077›Full record

ArticleNarra J2024

Predictors for 30-day mortality in hepatocellular carcinoma patients undergoing liver resection.

Erik Prabowo, Neni Susilaningsih, Catharina Suharti, Hery D Purnomo, Ignatius Riwanto, Ahmad F Fuadi, Ardiyana Ar, Beatrice LA Bulandari, Kevin C Tjandra, Danendra Rk Respati and 1 more

Abstract read
In one paragraph

Article in Narra J, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Erik PrabowoDoctoral Study Program of Medical and Health Science, Universitas Diponegoro, Semarang, Indonesia.
Neni SusilaningsihDepartment of Biomedicine, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia.
Catharina SuhartiDivision of Oncology Hematology, Department of Internal Medicine, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia.
Hery D PurnomoDivision of Gastroenterohepatology, Department of Internal Medicine, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia.
Ignatius RiwantoDivision of Digestive Surgery, Department of Surgery, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia.
Ahmad F FuadiDivision of Digestive Surgery, Department of Surgery, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia.
Ardiyana ArFaculty of Medicine, Universitas Diponegoro, Semarang, Indonesia.
Beatrice LA BulandariFaculty of Medicine, Universitas Diponegoro, Semarang, Indonesia.
Kevin C TjandraFaculty of Medicine, Universitas Diponegoro, Semarang, Indonesia.
Danendra Rk RespatiFaculty of Medicine, Universitas Diponegoro, Semarang, Indonesia.
Derren Dch RampenganFaculty of Medicine, Universitas Sam Ratulangi, Manado, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) ranks among the most prevalent and fatal liver cancers globally. Liver surgery, particularly resection, offers the potential for cure but poses challenges, especially in Indonesia, where patients often present in advanced stages. This study aimed to determine the intraoperative and perioperative factors associated with 30- day mortality of HCC patients undergoing liver resection at a tertiary referral hospital. The study included HCC patients undergoing liver resection at Karadi General Hospital, Semarang, Indonesia, between January 2018 and September 2023. Demographic data, intraoperative, perioperative, and postoperative factors were collected, with the primary outcome being 30-day mortality. Factors influencing 30-day survival were assessed using a log-rank test and the survival analysis employed Kaplan-Meier curves. Among 58 HCC patients who had liver resection, 62.1% were males, with a mean age was 57.27 ± 9.56 years. Preoperative comorbidities, notably hepatitis B, affected 34.4% of patients. Child-Pugh Score categorized 91.4% as class A. The study found a 30-day mortality rate of 10.3% with no subsequent increase in incidence. The failure-to-rescue rate (FTR) of this study was found 46%. Factors associated with 30-day mortality were Child-Pugh classification (

Indexed as

Carcinoma, HepatocellularHepatectomyLiver NeoplasmsAdultAgedFemaleHumansIndonesiaMaleMiddle AgedRisk Factorshepatocellular carcinomaLiver resectionmorbiditymortalitypredictive

Identifiers

PMID39816077
PMCPMC11731945

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.